C-reactive protein modifies lipoprotein(a)-related risk for coronary heart disease: the BiomarCaRE project
Natalie Arnold(Johannes Gutenberg University Mainz), Christoph Waldeyer(Universität Hamburg), Chiara Donfrancesco, Wolfgang Köenig(German Centre for Cardiovascular Research), Stefan Blankenberg(Universität Hamburg), Giancarlo Cesana(University of Milano-Bicocca), Licia Iacoviello(Istituto Neurologico Mediterraneo), Kari Kuulasmaa(Finnish Institute for Health and Welfare), Alina Goßling, Frank Kee(Queen's University Belfast), Tanja Zeller(Universität Hamburg), Stefan Söderberg(Umeå University), Hugh Tunstall‐Pedoe(University of Dundee), Christopher Blaum(Universität Hamburg), Allan Linneberg(Frederiksberg Hospital), Francisco Ojeda(Universidad Complutense de Madrid), Susana Sans(Health Research Institute of the Balearic Islands), Veikko Salomaa(Finnish Institute for Health and Welfare), Benjamin Bay(Universität Hamburg), Valerio Leoni(University of Milano-Bicocca), Jonas Andersson(Skellefteå Hospital), Pekka Jousilahti(Finnish Institute for Health and Welfare), Francesco Gianfagna(University of Insubria), Maurizio Ferrario(University of Insubria), Luigi Palmieri(Istituto Superiore di Sanità), Annette Peters(Zimmer Biomet (Netherlands)), Renate B. Schnabel(Universität Hamburg), Giovanni Veronesi(University of Insubria), Fabian J. Brunner, Barbara Thorand(Helmholtz Zentrum München), Paolo Brambilla(Azienda Ospedaliera San Gerardo), Teresa Padró(Instituto de Salud Carlos III)
Cited by 56
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.7k
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
|European Heart Journal|2024|2.4k
From Vulnerable Plaque to Vulnerable Patient
|Circulation|2003|2.3k